Cleared Traditional

K143314 - Progressive Orthopaedic Total Hip System

K143314 is an FDA 510(k) clearance for Progressive Orthopaedic Total Hip System, manufactured by The Progressive Orthopaedic Company, LLC. The device is a Class 2 Orthopedic device with product code LPH cleared through the Traditional 510(k) pathway after a 100-day FDA review.

K143314 · The Progressive Orthopaedic Company, LLC · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2015
Decision
100d
Days
Class 2
Risk

K143314 is an FDA 510(k) clearance for the Progressive Orthopaedic Total Hip System. Classified as Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented (product code LPH), Class II - Special Controls.

Submitted by The Progressive Orthopaedic Company, LLC (North Palm Beach, US). The FDA issued a Cleared decision on February 27, 2015 after a review of 100 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3358 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all The Progressive Orthopaedic Company, LLC devices

FDA 510(k) Submission Details - K143314

510(k) Number K143314 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 19, 2014
Decision Date February 27, 2015
Days to Decision 100 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
22d faster than avg
Panel avg: 122d · This submission: 100d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LPH Device Classification - Class 2, Special Controls

Product Code LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3358
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented

All 477
Devices cleared under the same product code (LPH) and FDA review panel - the closest regulatory comparables to K143314.
Echo Bi-Metric Microplasty Line Extension
K150503 · Biomet, Inc. · Mar 2015
Mpact Double Mobility System
K143453 · Medacta International · Mar 2015
PROCOTYL L-O ACETABULAR SYSTEM
K142119 · Microport Orthopedics, Inc. · Feb 2015
G7 Freedom and Offset Liners, Freedom Head, Size 32
K142882 · Biomet, Inc. · Feb 2015
Stryker Orthopaedics Acetabular Shells, Femoral Stems and Total Hip Instruments for use with the Direct Superior Approach
K143085 · Stryker Orthopaedics · Feb 2015
Trident® Tritanium® PST® Acetabular Shells
K142606 · Mako Surgical Corp. · Jan 2015